Kevin L. Farmer, Ph.D.
Affiliations: | 2010 | Physical Therapy & Rehabilitation Sciences | University of Kansas, Lawrence, KS, United States |
Area:
Neurotrophins, Pain, Diabetic NeuropathyGoogle:
"Kevin Farmer"Mean distance: 17.38 (cluster 24) | S | N | B | C | P |
Parents
Sign in to add mentorDouglas E. Wright | grad student | 2010 | University of Kansas | |
(The effect of voluntary exercise on neuropathic pain.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ma J, Farmer KL, Pan P, et al. (2014) Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy. The Journal of Pharmacology and Experimental Therapeutics. 348: 281-92 |
Farmer K, Williams SJ, Novikova L, et al. (2012) KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability. Experimental Diabetes Research. 2012: 671673 |
Farmer KL, Li C, Dobrowsky RT. (2012) Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacological Reviews. 64: 880-900 |
Kluding PM, Pasnoor M, Singh R, et al. (2012) The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. Journal of Diabetes and Its Complications. 26: 424-9 |
Urban MJ, Pan P, Farmer KL, et al. (2012) Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy. Experimental Neurology. 235: 388-96 |
Huang HH, Farmer K, Windscheffel J, et al. (2011) Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Experimental Diabetes Research. 2011: 481427 |